Doctor profile · Federal record

Dr. Mark Wernham, MS,PA-C

Medical Physician Assistant (CMS: Physician Assistant) · Medical Physician Assistant · Ithaca, NY

  • NPI 1205849981
  • Accepts Medicare
  • MIPS 92.3 / 100 · 2023
  • 20 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1051 Craft RD
Ithaca, NY 148501016
(607) 257-1107
fax (607) 257-0369
Mailing address
274 Chipman Corners RD
Groton, NY 130738405

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
February 8, 2023
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
363AM0700X — NUCC code
State licenses (2)
New York #019675-1 · New Jersey #25MP00163400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1205849981. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,693
Distinct HCPCS
10
Medicare allowed
$164,040
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,558 266 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 662 592 $74
17000 Destruction of precancer skin growth, 1 growth 367 337 $45
11102 Biopsy of related skin growth, first growth 327 306 $78
99203 New patient office or other outpatient visit, 30-44 minutes 183 183 $92
17110 Destruction of skin growth, 1-14 growths 146 128 $93
11103 Biopsy of related skin growth, each additional growth 142 95 $41
17004 Destruction of precancer skin growth, 15 or more growths 141 127 $139
99212 Established patient office or other outpatient visit, 10-19 minutes 101 95 $46
69100 Biopsy of ear 21 20 $55

In context: peer comparison

Among 2 peers in this city , average services per provider: 272. This provider delivers 14× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$991
Transactions
51
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Regeneron Healthcare Solutions, Inc. 8 $169.50
Lilly USA, LLC 9 $144.51
Novartis Pharmaceuticals Corporation 6 $116.77
Janssen Biotech, Inc. 4 $99.06
ABBVIE INC. 4 $82.15
SUN PHARMACEUTICAL INDUSTRIES INC. 4 $75.98
Amgen Inc. 3 $62.41
Galderma Laboratories, L.P. 2 $37.34
Arcutis Biotherapeutics, Inc. 2 $36.62
UCB, Inc. 2 $33.96
PFIZER INC. 2 $31.40
E.R. Squibb & Sons, L.L.C. 2 $29.68
Incyte Corporation 1 $23.20
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $17.39
Dermavant Sciences, Inc. 1 $16.57

By nature of payment

Food and Beverage
$862
Education
$129

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
613
Patients
306
Total drug cost
$33,191
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 100 71 $1,114
Ketoconazole Generic 72 39 $1,835
Metronidazole Generic 67 34 $4,618
Clobetasol Propionate Generic 66 34 $4,368
Clindamycin Phosphate Generic 47 18 $2,710
Nystatin Generic 42 23 $495
Mupirocin Generic 39 25 $517
Fluocinonide Generic 38 22 $3,469
Tacrolimus Generic 32 14 $6,743
Doxycycline Monohydrate Generic 22 0 $852

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Wernham's medical specialty?
Dr. Mark Wernham practices Medical Physician Assistant in Ithaca, NY.
Where does Dr. Mark Wernham practice?
Dr. Mark Wernham practices at 1051 Craft RD, Ithaca, NY 148501016. Office phone: 6072571107.
What is Dr. Mark Wernham's NPI?
Dr. Mark Wernham's National Provider Identifier (NPI) is 1205849981, issued by NPPES.
Does Dr. Mark Wernham accept Medicare assignment?
Yes. Dr. Mark Wernham accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Wernham commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.